Skip to main content
SpringerLink
Log in

Transcatheter Aortic Valve Replacement in Lower Surgical Risk Patients: Review of Major Trials and Future Perspectives

  • Valvular Heart Disease (A Wang, Section Editor)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Following the first successful transcatheter aortic valve replacement (TAVR) in 2002, TAVR has globally evolved to become a standard procedure in high-risk patients. Surgical aortic valve replacement in non-high-risk patients remains the gold standard for treatment of severe aortic stenosis. However, a paradigm shift appears to be occurring in the direction of treating lower-risk patients, and several studies have suggested its impact on clinical outcomes. In this review, we highlight the current status of TAVR in intermediate-risk patients and review major trials including Placement of AoRTic TraNscathetER (PARTNER) 2A randomized intermediate-risk trial using SAPIEN XT (Edwards Lifesciences Corp, Irvine, CA) recently presented with excellent outcomes and the lowest major complications rate at the American College of Cardiology’s 65th Annual Scientific Session in Chicago. Clinical trials in low-risk patients using SAPIEN 3 and CoreValve Evolut R have just been launched, and they are going to be important milestones in the TAVR field.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Ross Jr J, Braunwald E. Aortic stenosis. Circulation. 1968;38(1 Suppl):61–7. This study provides a natural history of aortic stenosis when symptom appears.

    PubMed  Google Scholar 

  2. Carabello BA, Paulus WJ. Aortic stenosis. Lancet. 2009;373(9667):956–66. This review discusses the pathophysiology, diagnosis, and treatment of aortic stenosis.

    Article  PubMed  Google Scholar 

  3. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106(24):3006–8. This report describes the first human case with transcatheter aortic valve replacement.

    Article  PubMed  Google Scholar 

  4. Harken DE, Soroff HS, Taylor WJ, Lefemine AA, Gupta SK, Lunzer S. Partial and complete prostheses in aortic insufficiency. J Thorac Cardiovasc Surg. 1960;40:744–62. This is the first report of surgical aortic valve replacement.

    CAS  PubMed  Google Scholar 

  5. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22):2438–88.

    Article  PubMed  Google Scholar 

  6. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC)1; European Association for Cardio-Thoracic Surgery (EACTS), Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33(19):2451–96. This is the current European guideline of valvular heart disease.

    Article  Google Scholar 

  7. Holmes Jr DR, Brennan JM, Rumsfeld JS, et al. STS/ACC TVT Registry. Clinical outcomes at 1 year following transcatheter aortic valve replacement. JAMA. 2015;313(10):1019–28.

    Article  CAS  PubMed  Google Scholar 

  8. Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010;122(1):62–9. This study provides the earlier TAVR experience in Europe.

    Article  PubMed  Google Scholar 

  9. Piazza N, Kalesan B, van Mieghem N, et al. A 3-center comparison of 1-year mortality outcomes between transcatheter aortic valve implantation and surgical aortic valve replacement on the basis of propensity score matching among intermediate-risk surgical patients. JACC Cardiovasc Interv. 2013;6(5):443–51.

    Article  PubMed  Google Scholar 

  10. Lange R, Bleiziffer S, Mazzitelli D, et al. Improvements in transcatheter aortic valve implantation outcomes in lower surgical risk patients: a glimpse into the future. J Am Coll Cardiol. 2012;59(3):280–7. This study provides outcomes in earlier experience in patients with lower-risk TAVR patients.

    Article  CAS  PubMed  Google Scholar 

  11. Wenaweser P, Stortecky S, Schwander S, et al. Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation. Eur Heart J. 2013;34(25):1894–905.

    Article  CAS  PubMed  Google Scholar 

  12. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–607. This study provides that TAVR is superior to standard medical therapy in terms of mortality.

    Article  CAS  PubMed  Google Scholar 

  13. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98. This study provides that TAVR is non-inferior to SAVR in terms of mortality.

    Article  CAS  PubMed  Google Scholar 

  14. Popma JJ, Adams DH, Reardon MJ, et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014;63:1972–81.

    Article  PubMed  Google Scholar 

  15. Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790–8.

    Article  CAS  PubMed  Google Scholar 

  16. Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol. 2012;60(15):1438–54. This study provides definition and clinical endpoint in TAVR.

    Article  PubMed  Google Scholar 

  17. Piazza N, Wenaweser P, van Gameren M, et al. Relationship between the logistic EuroSCORE and the Society of Thoracic Surgeons Predicted Risk of Mortality score in patients implanted with the CoreValve ReValving system—a Bern-Rotterdam Study. Am Heart J. 2010;159(2):323–9. This study provides the role of STS score and EuroSCORE in TAVR.

    Article  PubMed  Google Scholar 

  18. Abdel-Wahab M, Mehilli J, Frerker C, et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA. 2014;311(15):1503–14.

    Article  PubMed  Google Scholar 

  19. Gilard M, Eltchaninoff H, Iung B, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366(18):1705–15. This study provides information of large registry in France.

    Article  CAS  PubMed  Google Scholar 

  20. Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366(18):1686–95. This study provides impact of PVL after TAVR.

    Article  CAS  PubMed  Google Scholar 

  21. Clavel MA, Webb JG, Rodés-Cabau J, et al. Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction. Circulation. 2010;122(19):1928–36. This study provides information about the association between TAVR and better LVEF recovery compared with SAVR.

    Article  CAS  PubMed  Google Scholar 

  22. Kodali SK, Thorurani VH, White J et al. Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. Eur Heart J. 2016. In press.

  23. Nazif TM, Dizon JM, Hahn RT, et al. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. JACC Cardiovasc Interv. 2015;8(1 Pt A):60–9.

    Article  PubMed  Google Scholar 

  24. Thourani VH, Kodali S, Makkar RR et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016. In press.

  25. Thyregod HG, Steinbrüchel DA, Ihlemann N, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol. 2015;65(20):2184–94.

    Article  PubMed  Google Scholar 

  26. Leon MB, Smith CR, Mack MJ et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016. In press.

  27. Abdel-Wahab M, Comberg T, Büttner HJ, et al. Aortic regurgitation after transcatheter aortic valve implantation with balloon- and self-expandable prostheses: a pooled analysis from a 2-center experience. JACC Cardiovasc Interv. 2014;7(3):284–92.

    Article  PubMed  Google Scholar 

  28. Généreux P, Webb JG, Svensson LG, et al. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol. 2012;60(12):1043–52. This study provides information about association between mortality and major vascular complication in PARTNER trial.

    Article  PubMed  Google Scholar 

  29. Binder RK, Rodés-Cabau J, Wood DA, et al. Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve. JACC Cardiovasc Interv. 2013;6(3):293–300.

    Article  PubMed  Google Scholar 

  30. Piazza N, Martucci G, Lachapelle K. First-in-human experience with the Medtronic CoreValve Evolut R. EuroIntervention. 2014;9(11):1260–3.

    Article  PubMed  Google Scholar 

  31. Buellesfeld L, Stortecky S, Heg D, et al. Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation. J Am Coll Cardiol. 2012;60(6):493–501. This study provides information about association between pacemaker implantation after TAVR and mortality.

    Article  PubMed  Google Scholar 

  32. Kapadia SR, Leon MB, Makkar RR, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385(9986):2485–91.

    Article  PubMed  Google Scholar 

  33. Dvir D. Half of transcatheter heart valves show degeneration within 10 years of TAVI. Available at http://www.eurekalert.org/pub_releases/2016-05/p-e2h051616.php. Accessed 17 May 2016.

  34. Lawrence S. Edwards works to expand TAVR into intermediate risk, elderly patients to hit $5B market. Available at: http://www.fiercemedicaldevices.com/story/edwards-works-expand-tavr-intermediate-risk-elderly-patients-hit-5b-market/2016-01-15. Accessed 29 Mar 2016.

Download references

Author information

Authors and Affiliations

  1. Advanced Cardiac Valve Center, Department of Medicine, Division of Cardiovascular Medicine, University of Virginia, 1215 Lee Street, Hospital Expansion, Room 4033, Charlottesville, VA, 22908, USA

    Mike Saji & D. Scott Lim

  2. Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan

    Mike Saji

Authors
  1. Mike Saji
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Scott Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Scott Lim.

Ethics declarations

Conflict of Interest

Mike Saji and D. Scott Lim declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Valvular Heart Disease

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saji, M., Lim, D.S. Transcatheter Aortic Valve Replacement in Lower Surgical Risk Patients: Review of Major Trials and Future Perspectives. Curr Cardiol Rep 18, 103 (2016). https://doi.org/10.1007/s11886-016-0772-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11886-016-0772-3

Keywords

Search

Navigation